HomeVYGR • NASDAQ
add
Voyager Therapeutics Inc
Previous close
$4.35
Day range
$4.23 - $4.40
Year range
$2.65 - $6.69
Market cap
237.97M USD
Avg Volume
505.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.36M | -45.73% |
Operating expense | 8.09M | -0.92% |
Net income | -27.89M | -208.40% |
Net profit margin | -208.69 | -468.33% |
Earnings per share | -0.47 | -193.75% |
EBITDA | -29.66M | -134.52% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 208.93M | -39.50% |
Total assets | 288.31M | -32.33% |
Total liabilities | 68.49M | -28.46% |
Total equity | 219.82M | — |
Shares outstanding | 55.60M | — |
Price to book | 1.10 | — |
Return on assets | -25.06% | — |
Return on capital | -28.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -27.89M | -208.40% |
Cash from operations | -31.05M | -11.01% |
Cash from investing | 34.89M | -45.79% |
Cash from financing | 85.00K | 507.14% |
Net change in cash | 3.92M | -89.22% |
Free cash flow | -19.99M | -11.07% |
About
Founded
2013
Headquarters
Website
Employees
172
